Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...

Pfizer's oral HER2 inhibitor Tukysa looks poised to find a new role as first-line maintenance therapy for HER2-positive ...

This shift matters because the pharmaceutical industry carries material weight. The sector is estimated to be responsible for ...

The results of the lidERA trial in patients with HR-positive, HER2-negative early breast cancer – previewed last month and ...

The deal focuses on a weight-loss pill in development at YaoPharma, a GLP-1 agonist codenamed YP05002, which is currently in ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a ...

Chambers discusses her personal experience as a GP in the NHS, including the discrimination she faced as a woman, and ...

Today, the EU Council and Parliament reached an agreement in principle on the long-awaited pharma reform package, but ...

Menopause is another major area. “Many women can’t tolerate oral progesterone. If they’re on oestrogen and have a uterus, ...

The other new piece to MFN in its current incarnation is the direct-to-patient platform TrumpRX, and the promise that MFN ...

Artificial intelligence (AI) is reshaping industries across the board, but nowhere are the stakes higher than in life ...

AI-driven customer centricity is built on a continuously learning system that interprets behaviour, identifies intent, and ...